Spots Global Cancer Trial Database for uterine carcinosarcoma

Every month we try and update this database with for uterine carcinosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of INCB123667 in Subjects With Advanced Solid Tumors	NCT05238922	Solid Tumors	INCB0123667	18 Years -	Incyte Corporation
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors	NCT05229601	Soft Tissue Sar... Renal Cell Carc... Uterine Carcino... Hepatocellular ... Head and Neck S... Melanoma	HFB301001	18 Years -	HiFiBiO Therapeutics
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma	NCT00390234	Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	ziv-aflibercept	18 Years -	National Cancer Institute (NCI)
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)	NCT03694262	Endometrial Can... Uterine Carcino...	Rucaparib Bevacizumab Atezolizumab	18 Years -	Medical College of Wisconsin
Chemotherapy in Treating Patients With Sarcoma of the Uterus	NCT00005643	Endometrial Can... Sarcoma	pegylated lipos...	21 Years -	GOG Foundation
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer	NCT01168232	Recurrent Uteri... Uterine Carcino...	Ixabepilone Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus	NCT00002546	Sarcoma	cisplatin ifosfamide adjuvant therap... radiation thera...	21 Years - 120 Years	GOG Foundation
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus	NCT00002459	Endometrial Can... Sarcoma	radiation thera...	-	European Organisation for Research and Treatment of Cancer - EORTC
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus	NCT00025506	Recurrent Uteri... Uterine Carcino...	Laboratory Biom... Thalidomide	-	National Cancer Institute (NCI)
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma	NCT00006357	Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	imatinib mesyla...	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer	NCT00112489	Sarcoma	carboplatin paclitaxel	18 Years - 120 Years	GOG Foundation
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	NCT01010126	Adult Hepatocel... Advanced Adult ... Endometrial Ser... Localized Non-R... Lung Carcinoid ... Malignant Pancr... Malignant Pancr... Malignant Pancr... Malignant Pancr... Metastatic Dige... Ovarian Carcino... Ovarian Endomet... Ovarian Seromuc... Ovarian Serous ... Pancreatic Alph... Pancreatic Beta... Pancreatic Delt... Pancreatic G-Ce... Pancreatic Poly... Recurrent Adult... Recurrent Diges... Recurrent Fallo... Recurrent Ovari... Recurrent Pancr... Recurrent Prima... Recurrent Uteri... Regional Digest... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	Bevacizumab Temsirolimus	18 Years -	National Cancer Institute (NCI)
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus	NCT00003128	Sarcoma	filgrastim ifosfamide paclitaxel	18 Years -	GOG Foundation
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus	NCT00003128	Sarcoma	filgrastim ifosfamide paclitaxel	18 Years -	GOG Foundation
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus	NCT00003156	Sarcoma	topotecan hydro...	-	GOG Foundation
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma	NCT05147558	Uterine Carcino... Advanced Uterin...	Pembrolizumab Lenvatinib	18 Years -	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
Study of INCB123667 in Subjects With Advanced Solid Tumors	NCT05238922	Solid Tumors	INCB0123667	18 Years -	Incyte Corporation
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Study of INCB123667 in Subjects With Advanced Solid Tumors	NCT05238922	Solid Tumors	INCB0123667	18 Years -	Incyte Corporation
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Thalidomide in Treating Patients With Gynecologic Sarcomas	NCT00006005	Endometrial Can... Sarcoma	thalidomide	-	National Cancer Institute (NCI)
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer	NCT01367301	Stage IA Uterin... Stage IB Uterin... Stage IC Uterin... Stage IIA Uteri... Stage IIB Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	paclitaxel carboplatin external beam r... brachytherapy intensity-modul... laboratory biom...	18 Years -	Albert Einstein College of Medicine
Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT00478426	Endometrial Ade... Endometrial End... Endometrial Ser... Recurrent Uteri... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors	NCT05229601	Soft Tissue Sar... Renal Cell Carc... Uterine Carcino... Hepatocellular ... Head and Neck S... Melanoma	HFB301001	18 Years -	HiFiBiO Therapeutics
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer	NCT03902379	Endometrial Car... Stage 0 Fallopi... Stage I Fallopi... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage II Cervic... Stage II Fallop... Stage II Ovaria... Stage II Uterin... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage III Cervi... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage III Uteri... Stage IIIA Cerv... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Uteri... Uterine Carcino... Uterine Corpus ...	Internet-Based ... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)	NCT03694262	Endometrial Can... Uterine Carcino...	Rucaparib Bevacizumab Atezolizumab	18 Years -	Medical College of Wisconsin
EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma	NCT05619913	Ovarian Carcino... Uterine Carcino...	Eribulin Mesyla... Pembrolizumab	18 Years -	Australia New Zealand Gynaecological Oncology Group
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma	NCT05147558	Uterine Carcino... Advanced Uterin...	Pembrolizumab Lenvatinib	18 Years -	Memorial Sloan Kettering Cancer Center
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer	NCT01132547	Cancer	cyproheptadine ... placebo	2 Years - 21 Years	University of South Florida
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus	NCT00025506	Recurrent Uteri... Uterine Carcino...	Laboratory Biom... Thalidomide	-	National Cancer Institute (NCI)
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus	NCT01061606	Recurrent Uteri... Uterine Carcino...	temsirolimus	18 Years -	National Cancer Institute (NCI)
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma	NCT00002641	Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma	filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera...	16 Years - 69 Years	European Organisation for Research and Treatment of Cancer - EORTC
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer	NCT00954174	Mixed Mesoderma... Ovarian Carcino... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IA Uterin... Stage IB Fallop... Stage IB Ovaria... Stage IB Uterin... Stage IC Fallop... Stage IC Ovaria... Stage IC Uterin... Stage II Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Uteri... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Uteri... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	Carboplatin Ifosfamide Paclitaxel Quality-of-Life...	18 Years -	GOG Foundation
Chemotherapy in Treating Patients With Sarcoma of the Uterus	NCT00005643	Endometrial Can... Sarcoma	pegylated lipos...	21 Years -	GOG Foundation
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors	NCT05229601	Soft Tissue Sar... Renal Cell Carc... Uterine Carcino... Hepatocellular ... Head and Neck S... Melanoma	HFB301001	18 Years -	HiFiBiO Therapeutics
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer	NCT00112489	Sarcoma	carboplatin paclitaxel	18 Years - 120 Years	GOG Foundation
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer	NCT05902988	Advanced Solid ... High Grade Sero... Squamous Non-sm... Triple Negative... Gastric Adenoca... Colorectal Aden... Esophageal Squa... Esophageal Aden... Gastroesophagea... Transitional Ce... Head and Neck S... Ovarian Carcino... Uterine Carcino... Uterine Serous ... Endometrium Can... Chromosomal Ins...	VLS-1488	18 Years -	Volastra Therapeutics, Inc.
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer	NCT01367301	Stage IA Uterin... Stage IB Uterin... Stage IC Uterin... Stage IIA Uteri... Stage IIB Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	paclitaxel carboplatin external beam r... brachytherapy intensity-modul... laboratory biom...	18 Years -	Albert Einstein College of Medicine
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer	NCT00114218	Recurrent Uteri... Uterine Carcino...	Gemcitabine Hyd... Docetaxel	-	GOG Foundation
Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer	NCT01247571	Recurrent Uteri... Uterine Carcino...	Pazopanib Hydro...	18 Years -	National Cancer Institute (NCI)
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma	NCT00687687	Uterine Carcino...	paclitaxel carboplatin BSI-201 (Inipar...	18 Years -	Sanofi
Thalidomide in Treating Patients With Gynecologic Sarcomas	NCT00006005	Endometrial Can... Sarcoma	thalidomide	-	National Cancer Institute (NCI)
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer	NCT00075400	Recurrent Uteri... Uterine Carcino...	imatinib mesyla... laboratory biom...	-	National Cancer Institute (NCI)
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer	NCT01367301	Stage IA Uterin... Stage IB Uterin... Stage IC Uterin... Stage IIA Uteri... Stage IIB Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... Uterine Carcino...	paclitaxel carboplatin external beam r... brachytherapy intensity-modul... laboratory biom...	18 Years -	Albert Einstein College of Medicine
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma	NCT00245102	Adult Angiosarc... Adult Epithelio... Adult Leiomyosa... Adult Malignant... Adult Neurofibr... Adult Synovial ... Ovarian Sarcoma Recurrent Adult... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	sorafenib tosyl...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: